Version française
English Version
Version D
Version I
Version E

Biotechnologies Pharmaceuticals

ABBOTT SPINE
Staff: 54
BORDEAUX
More: Site Web
BEYNEL MANUSTOCK
Staff: 220
BELIN BELIET
More: Site Web
CEVA Santé Animale
Group staff: 1732
LIBOURNE
More: Site Web
COMIPSO SA
Staff: 5
Bordeaux
More: Site Web
CREAPHARM Développement
Staff: 50
LE HAILLAN
More: Site Web
ELLIPSE PHARMACEUTICALS
Staff: 15
PESSAC
More: Site Web
FLAMEL TECHNOLOGIES - Unité de Production
Group staff: 170
PESSAC
More: Site Web
FLUOFARMA
Staff: 7
PESSAC
More: Site Web
GALENIX Groupe
Group Staff: 70
ST JEAN D'ILLAC
More: Site Web
IMAGE GUIDED THERAPY
Staff: 10
PESSAC
More: Site Web
LABSO CHIMIE FINE
Staff: 60
BLANQUEFORT
More: Site Web
LEMI
Staff: 11
MARTILLAC
More: Site Web
McNeil Research&Development Europe
Group Staff: 12
MARTILLAC
More: Site Web
MEDA PHARMA
Staff: 180
MERIGNAC
More: Site Web
MITOPROD
Staff: 10
PESSAC
More: Site Web
PANTHER
Staff: 58
GRADIGNAN
More: Site Web
REACTIFS R.A.L.
Staff: 30
MARTILLAC
More: Site Web
SANOFI-AVENTIS
Staff: 830
CARBON BLANC
More: Site Web
SERONO France, Etablissement de Martillac
Staff: 60
MARTILLAC
More: Site Web
STRYKER SPINE
Group staff: 268
CESTAS
More: Site Web

More information

 
what happens to a static route entry in a routing table when the outgoing interface is not available